| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Studies of the regulation of surfactant lipoprotein metabolism and secretion and surfactant protein gene expression have been hampered by the lack of a cell culture system in which the phenotypic properties of type II
cells are maintained. We have developed a primary culture system that facilitates the maintenance of a number
of morphologic and biochemical properties of type II pneumonocytes for up to 2 wk. Cells were isolated by
collagenase digestion of midgestation human fetal lung tissue that had been maintained in organ culture in the
presence of dibutyryl cyclic AMP (Bt2cAMP) for 5 days. The isolated cells were enriched for epithelial components by treatment with DEAE-dextran, plated on an extracellular matrix (ECM) derived from Madin-Darby canine kidney (MDCK) cells, and incubated at an air/liquid interface in a minimal amount of culture medium containing Bt2cAMP. The cell cultures were comprised of islands of round epithelial-like cells containing numerous dense osmiophilic granules, surrounded by sparse spindle-shaped cells with the appearance
of fibroblasts. Ultrastructural examination revealed that the osmiophilic granules had the appearance of lamellar bodies, the distinguishing feature of type II pneumonocytes. Additionally, the cultures maintained elevated
levels of SP-A gene expression for up to 2 wk. The expression of mRNAs encoding SP-A, SP-B, and SP-C
were regulated in the cultured cells by glucocorticoids and cyclic AMP in a manner similar to that observed in
fetal lung tissue in organ culture. The differentiated phenotype was most apparent when the cells were cultured
at an air/liquid interface. In order to utilize the cultured type II cells for study of the effects of overexpression
of various proteins and for promoter analysis, it is of essence to transfect DNA constructs into these cells with
high efficiency. Unfortunately, we found the cells to be refractory to efficient transfer of DNA using conventional methods (i.e., lipofection, electroporation, or calcium phosphate-mediated transfection). However, replication-defective recombinant human adenoviruses were found to provide a highly efficient means of introducing DNA into the type II pneumonocytes. Furthermore, we observed in type II cell-enriched cultures infected
with recombinant adenoviruses containing the lacZ gene under control of a cytomegalovirus promoter, that
-galactosidase was expressed uniformly in the islands of type II cells and surrounding fibroblasts. By contrast, in cultures infected with recombinant adenoviruses containing the human growth hormone (hGH) gene
under control of the SP-A gene promoter and 5'-flanking region, hGH was expressed only in the type II cells.
Thus, this culture system provides an excellent means for identifying genomic elements that mediate type II
cell-specific gene expression.
| |
Introduction |
|---|
|
|
|---|
Pulmonary alveolar type II cells carry out highly specialized functions that include the synthesis, secretion, and reutilization of surfactant, a surface-active lipoprotein which acts to reduce surface tension at the alveolar air-liquid interface (1) and is essential for normal breathing. Type II cells are unique in their ability to produce surfactant which contains relatively large amounts of dipalmitoylphosphatidylcholine (DPPC), a saturated glycerophospholipid with singular surface-active properties, and store surfactant lipids and proteins in organelles termed lamellar bodies. Type II cells synthesize four lung-specific surfactant-associated proteins, SP-A, SP-B, SP-C, and SP-D, which serve a number of important functions (2). Surfactant synthesis is initiated in type II cells only after 75% of gestation is complete (3). Surfactant synthesis by the fetal lung is regulated by a number of hormones and factors, including glucocorticoids and agents that increase cyclic AMP (4, 5).
To define the molecular mechanisms involved in developmental, hormonal, and type II cell-specific regulation of surfactant synthesis in fetal lung, we have focused on the gene encoding SP-A, a major surfactant protein that is synthesized primarily by type II pneumonocytes and to a lesser extent in nonciliated bronchioalveolar epithelial (Clara) cells (6, 7). SP-A gene expression is developmentally regulated in fetal lung in concert with the induction of surfactant glycerophospholipid synthesis (8, 9) and with the appearance of differentiated type II cells. SP-A appears to serve a number of critical roles, including facilitation of tubular myelin formation (10), enhancing the rapid adsorption of DPPC to an air-liquid interface (11), mediating reutilization of surfactant phospholipids and proteins (12), and activating immune defense within the alveolus (13, 14).
SP-A gene expression is undetectable in fetal lung at
mid-gestation. When human fetal lung explants are placed
in organ culture in serum-free medium they differentiate
spontaneously and develop the capacity for synthesis of surfactant glycerophospholipids and SP-A (15). Treatment of
the lung explants with the cAMP analogue dibutyryl cAMP
(Bt2cAMP) increases the rate of appearance of type II
pneumonocytes, as well as the rate of SP-A gene transcription (16, 17). The factors that cause spontaneous differentiation of the cultured lung explants have not been defined.
However, we have found that the mid-gestation human fetal lung explants produce relatively high levels of the prostanoids, PGE2, TXA2, and PGI2, and that inhibition of cyclooxygenase activity by indomethacin treatment causes a
pronounced reduction in cyclic AMP formation and prevents the spontaneous induction of SP-A gene expression (18). In other studies, we observed that spontaneous differentiation and cyclic AMP induction of SP-A gene expression in the cultured lung tissue is dependent upon the oxygen tension of the environment; at environmental oxygen
tensions of
5% the effect of Bt2cAMP to induce SP-A
gene expression was abolished (19).
The organ culture system provides an effective means for promoting and maintaining type II cell differentiation, which likely depends upon precise cellular interactions and tissue architecture. In this regard, organ culture affords a powerful system for study of the multifactorial regulation of synthesis of surfactant lipids and proteins. However, the absence of cell lines or of a primary culture system in which phenotypic properties of type II pneumonocytes are maintained, has hampered the progress of studies of the regulation of surfactant secretion and reutilization, and the implementation of DNA transfection studies to functionally map regulatory elements of type II cell-specific genes. In the present study, we have developed a primary type II cell-enriched culture system in which major morphologic and biochemical properties of type II cells are sustained for up to 2 wk. By use of recombinant replication of defective human adenoviruses, we have found that reporter gene constructs containing sequences flanking the 5'-end of the SP-A gene are expressed specifically in islands of type II cells, but not in the surrounding fibroblasts. Thus, this system provides an excellent model for studies of cis-acting elements involved in type II cell-specific expression of lung-specific genes.
| |
Materials and Methods |
|---|
|
|
|---|
Organ Culture and Type II Pneumonocyte Isolation and Primary Culture
The procedure used to isolate and maintain type II pneumonocytes in primary culture is outlined in Figure 1. Lung tissues from mid-trimester human abortuses were obtained in accordance with the Donors Anatomical Gift Act of the State of Texas; consent forms and protocols were approved by the Human Research Review Committee of the University of Texas Southwestern Medical Center at Dallas. The tissues were minced (1-2 mm3) and cultured on lens paper (#11-996; Fisher Scientific, Pittsburgh, PA) supported by stainless steel grids in serum-free Waymouth's MB752/1 medium (#51400; Gibco/BRL Inc., Gaithersburg, MD) in the presence of dibutyryl cAMP (1 mM, Bt2cAMP, #104396; Boehringer Mannheim Corp., Indianapolis, IN) as described previously (16). After 5 days of organ culture with daily medium changes, lung explants were dissociated by digestion with collagenase type I (0.5 mg/ml, C-0130; Sigma Chemical Co., St. Louis, MO) and collagenase type IA (0.5 mg/ml, C-9891; Sigma Chemical Co.) for 15 min at 37°C with vigorous pipeting. Following collagenase digestion, the cells were treated with DEAE-dextran (250 µg/ml; Sigma Chemical Co.) and incubated for 45 min with shaking at 37°C. We have found that DEAE-dextran treatment selectively eliminates fibroblasts. The cells were pelleted at 400 × g and plated either onto TranswellTM dishes (#3425; Costar Corp., Cambridge, MA) (1-2 × 106 cells per dish), on 60-mm tissue culture dishes or on Thermanox coverslips (#5413; Nunc, Inc., Naperville, IL) that were coated with extracellular matrix (ECM) prepared by derived from MDCK cells (ATCC CCL34) (2-5 × 106 cells per 60-mm dish). The extracellular matrix-coated dishes were prepared from confluent monolayers of MDCK cells that were treated with deoxycholate (1%) for 5 min. The dishes were washed 3 times with Hank's balanced salt solution and stored at 37°C until used. Plated epithelial cell-enriched cultures were incubated overnight in Waymouth's medium with 10% fetal bovine serum (#16000; Gibco/BRL Inc.). Dishes were washed twice with medium to eliminate dead and non-adherent cells, and then incubated in Waymouth's MB752/1 medium without fetal bovine serum. In studies where type II pneumonocytes were plated onto TranswellTM dishes, culture medium was placed either below or above and below the cell monolayer. The plating density of the cells after overnight incubation was approximately 50-60%.
|
|
|
Osmium Tetroxide Staining of Lamellar Bodies in Type II Pneumonocytes in Primary Culture
To assess the presence of lamellar bodies in the cultured type II pneumonocytes, a modification of the method of Mason and associates (20) was used. The cells were plated onto ECM-coated Thermanox coverslips and cultured in serum-free medium containing Bt2cAMP. Prior to analysis, the cells were rinsed in phosphate-buffered saline (PBS, pH 7.3) and fixed with glutaraldehyde (1.5% in PBS) for 15 min. The cells were then washed twice and treated with osmium tetroxide (1.0%; Sigma Chemical Co.) in PBS for 90 min at room temperature. The cells were subsequently washed twice and incubated in tannic acid (1.0% in PBS, pH 6.8) overnight. After washing with PBS, the cells were examined and photographed under light microscopy.
Electron Microscopy of Type II Pneumonocytes in Primary Culture
For analysis of the ultrastructure of the cultured type II pneumonocytes, transmission electron microscopy was performed. The cultured cells were scraped from the dishes, fixed in glutaraldehyde (2%), and routinely processed for electron microscopy (21). In brief, the cells were dehydrated in graded alcohols, embedded in resin, sectioned, and stained with lead citrate and uranyl acetate. Sections were viewed and photographed with a JEOL 100SX (Japan Electronic Optic Laboratories USA, Inc., Boston, MA) scanning electron microscope.
Immunoblot Analysis of SP-A Protein
Cellular proteins were isolated as described previously (22). Briefly, cells were scraped off the plates with a rubber policeman and homogenized in ice-cold homogenization buffer (0.25 M sucrose, 10 mM Tris-HCl [pH 7.4], 1 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride [PMSF]) using 10 strokes in a Teflon-glass homogenizer. The homogenized samples were pelleted at 600 × g for 5 min to remove debris, and the resulting homogenate was assayed for protein content. Cellular proteins (50 µg) were subjected to one-dimensional sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and the separated proteins transferred to nitrocellulose by electrophoretic transfer. The samples on the resulting blot were analyzed for SP-A content as described previously (23); the blot was incubated with rabbit anti-human SP-A immunoglobulin G (IgG) and 125I-labeled goat anti-rabbit IgG. The blots were subjected to autoradiography using Kodak X-OMAT radiographic film (#165 1579; Eastman Kodak Co., Rochester, NY) for visualization of the resulting protein-antibody complexes. Relative amounts of protein were assessed by scanning densitometry of the autoradiograms.
Northern Analysis of Type II Pneumonocyte mRNA
Total RNA was extracted from the cells by homogenization in guanidinium isothiocyanate (4.0 M) using a Teflon-glass homogenizer. The cell extracts were centrifuged through a cesium chloride gradient (5.7 M), and the pelleted RNA was resuspended in water (24). Total RNA (15 µg) was electrophoresed, transferred to nitrocellulose, and probed using either a 32P-labeled rabbit SP-A cDNA, rabbit SP-B cDNA, or rabbit SP-C cDNA, as described in detail previously (25). The relative levels of mRNA were assessed by autoradiography using Kodak X-OMAT radiographic film.
Transfection of Human Type II Pneumonocytes with Recombinant Adenovirus
A recombinant replication-defective human adenovirus
containing 991 base pairs of sequence flanking the 5'-end
of the rabbit SP-A linked to the human growth hormone
(hGH) structural gene, as reporter (Ad:SP-A
991:hGH),
was constructed as described previously (28). A recombinant replication-defective adenovirus containing the gene
encoding bacterial
-galactosidase (lacZ) driven by the cytomegalovirus early (E1) promoter (AdCMV:lac) has
been described elsewhere (29). Type II pneumonocytes
were infected with adenovirus for transfection of reporter
genes as described previously (28). Briefly, type II pneumonocytes were plated onto 60-mm ECM-coated dishes
and maintained overnight in Waymouth's MB752/1 medium containing fetal calf serum (10%, v/v). The cells were
then washed several times with medium to remove non-adherent cells and debris, and incubated for 1 h with recombinant adenovirus. The medium was then replaced
with fresh medium.
Immunocytochemical Analysis of hGH and
-galactosidase
in Transfected Human Type II Pneumonocytes
Cells to be infected with recombinant adenoviruses were
plated onto ECM-coated Thermanox glass coverslips, as
described above. After DNA transfection, cells were incubated as described above until day 5 of culture, when the
cells were fixed with formaldehyde (3.7%) in PBS for
10 min. To visualize nuclear
-galactosidase, the cells were
incubated in PBS containing 5 mM potassium ferricyanate, 5 mM potassium ferrocyanate, 1 mM MgSO4, and 0.5%
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-gal)
at 37°C. When a blue color indicating the presence of
-galactosidase was observed, the cells were washed twice
with PBS. To visualize the presence of hGH, the cells were
permeabilized with NET/gel (50 mM Tris-HCl, 1 mM
EDTA, 150 mM NaCl, 0.25% gelatin, 0.05% NP-40,
0.01% sodium azide, pH 8.0) and Triton X-100 (0.1%) for
30 min prior to antibody addition. The coverslips then
were treated with rabbit IgG specific for hGH (50 µg/ml;
Dako Corp., Carpinteria, CA) in NET/gel (without Triton
X-100) for 60 min. The blot was then treated with the components of the Vectastain Elite ABC kit (#PK-6101; Vector
Labs, Burlingame, CA) to promote the binding of horseradish peroxidase to the hGH/antibody complexes. Visualization of the complexes as red granules was accomplished by
use of the aminoethyl carbazole substrate kit from Zymed
Laboratories (#00-2007; Zymed Labs. Inc., San Francisco,
CA).
Quantitative Analysis of hGH Production in Transfected Human Type II Pneumonocytes
Media from cells infected with the AdSP-A
991:hGH recombinant adenovirus were collected at 24-h intervals.
The concentration of hGH in the medium was quantitated
by radioimmunoassay using an Allegro hGH kit (Nichols
Institute Diagnostics, San Juan Capistrano, CA).
| |
Results |
|---|
|
|
|---|
Type II Pneumonocytes Isolated from Human Fetal Lung Explants Maintain the Characteristics of Type II Cells in Primary Monolayer Culture
In developing a method for isolation and culture of differentiated type II cells, a number of factors were considered. First, we previously observed that fetal lung explants differentiate when maintained in organ culture in serum-free medium; there is spontaneous appearance of type II cells and induced synthesis of surfactant phospholipids (15) and SP-A (16). Furthermore, we found that addition of Bt2cAMP to the culture medium increased the rate of type II cell differentiation and SP-A gene transcription (16, 30, 31). In fact, after several days of organ culture, ~ 50% of the cell population in the lung explants is comprised of type II pneumonocytes (16). Thus, there is a marked enrichment of type II cells in the cultured fetal lung explants as compared to late fetal, neonatal, or adult lung in situ, in which it is estimated that type II cells comprise only 10-15% of the cell population. Second, in our prior attempts to transfect DNA into lung cell suspensions, we serendipitously observed that DEAE-dextran (250 µg/ml) eliminated the majority of fibroblasts, resulting in a relatively pure population of alveolar epithelial cells (32). Finally, in light of the potentially important role of extracellular matrix (ECM) in the maintenance of alveolar epithelial cell differentiation (33, 34), the isolated type II pneumonocytes were cultured on ECM derived from MDCK cells. The method for type II cell isolation and culture is diagrammed in Figure 1.
We observed that the cultured cells contained numerous lamellar bodies, the major morphologic characteristic of type II pneumonocytes (35), for at least 5 days after the initiation of primary culture. Shown in Figure 2 is a light micrograph of a typical cluster of type II pneumonocytes after 5 days of culture in serum-free medium containing Bt2cAMP. The cells, which were stained for the presence of lamellar bodies using osmium tetroxide (20), contained numerous large osmiophilic granules clustered around the nuclei. By electron microscopy, it is evident that these granules have the morphologic characteristics of lamellar bodies (Figure 3B) (36) and many of the cells contain these granules (Figure 3A). In addition, in all of the micrographs taken of the cells, we always observed a cuboidal morphology regardless of the plane of the section, suggesting that the cells isolated have the phenotypic properties of type II cells.
Type II Pneumonocytes in Primary Culture Maintain Expression of SP-A for Up to 14 Days
Type II pneumonocytes, when isolated from adult lung and plated on plastic culture dishes, have been reported to rapidly lose morphologic properties of type II cells and the ability to synthesize surfactant phospholipids and SP-A (33, 37). To ascertain the differentiated state of the fetal type II cells in the culture system developed in the present study, the levels of SP-A were analyzed by immunoblot analysis of cell lysates as a function of time in culture. The cells were cultured in 60-mm dishes in 1 ml of serum-free Waymouth's medium containing Bt2cAMP with daily medium change for up to 14 days. As can be seen in the autoradiogram in Figure 4, the amount of immunoreactive SP-A appeared relatively low in the fetal lung explants that had been incubated for 5 days in the presence of Bt2cAMP prior to cell isolation (ST). The amount of immunoreactive SP-A increased in the isolated cells through day 8 of culture and remains relatively constant throughout day 14. It should be noted that the levels of immunoreactive SP-A appeared low in the cultured lung explants (ST) relative to the cultured cells, because the extremely high levels of SP-A in the cultured type II cells necessitated a short exposure time of the autoradiogram. In fact, the levels of immunoreactive SP-A in the cultured explants were comparable to those observed in previous studies (16, 17). The high levels of SP-A expression in the type II cell cultures as compared with the fetal lung explants is due, in part, to the marked enrichment of type II cells in the former, as well as to undefined features of the cell culture system that enhance type II cell phenotypic properties which have not as yet been defined.
|
Expression of Genes Encoding SP-A, SP-B, and SP-C Are Regulated by Cyclic AMP and Glucocorticoids in Type II Pneumonocytes in Primary Culture
To analyze mRNA levels for SP-A, as well as the other surfactant proteins SP-B and SP-C in the cultured type II cells,
as well as the effects of cyclic AMP and glucocorticoids, we
analyzed the steady-state levels of mRNAs encoding the
surfactant proteins in cells after 5 days of primary culture in
the absence or presence of Bt2cAMP (1 mM) and dexamethasone (10
10 to 10
7 M), added alone or in combination. After culture, total RNA isolated from the cells was
analyzed for SP-A, SP-B, and SP-C mRNA transcripts by
Northern blotting using radiolabeled cDNAs for rabbit
SP-A (25), SP-B, and SP-C (the SP-B and SP-C cDNAs
were a gift from Dr. V. Boggaram, University of Texas
Health Science Center at Tyler, TX). As can be seen in
Figure 5A, SP-A mRNA levels in type II cells incubated
with Bt2cAMP were markedly increased over those of
cells incubated in control medium. As can be seen in the
autoradiogram in Figure 5B, dexamethasone had a dose-dependent biphasic effect on SP-A mRNA levels in type II
cells co-incubated with Bt2cAMP; dexamethasone at 10
10
M increased SP-A mRNA levels as compared with those
observed in cells incubated with Bt2cAMP alone, whereas,
at concentrations
10
9 M, dexamethasone antagonized the
stimulatory effect of Bt2cAMP. These effects of Bt2cAMP
and dexamethasone on SP-A mRNA are similar to those
observed using human fetal lung tissue in organ culture (38).
|
As can be seen in Figure 5C, SP-B mRNA levels in the cultured type II cells were increased by Bt2cAMP and by dexamethasone as compared with those of untreated cells. In type II cells incubated with Bt2cAMP and dexamethasone in combination, there was an apparent synergistic induction of SP-B mRNA levels. On the other hand, SP-C mRNA levels were not detectably altered by Bt2cAMP treatment. Dexamethasone had a modest effect to increase the levels of SP-C mRNA; in type II cells incubated with Bt2cAMP and dexamethasone in combination, SP-C mRNA was increased to levels that were greater than those observed with dexamethasone alone.
Primary Culture of Type II Pneumonocytes in TranswellTM Dishes: Effect of Medium Placement on SP-A Expression
TranswellTM dishes were originally designed for analysis of regulated secretion by polarized epithelial cells. The dishes contain a collagen-coated membrane platform with upper and lower chambers for placement of medium. In this study, we analyzed the effects of medium placement in the lower chamber only with medium placement in both upper and lower chambers on the levels of immunoreactive SP-A in human fetal type II cells in primary culture. Type II pneumonocytes were isolated from cultured human fetal lung explants, as described above, and plated in serum-free medium containing Bt2cAMP (1 mM) either on ECM-coated 60-mm culture dishes (volume of medium = 1 ml), or on TranswellTM dishes with serum-free medium in both the upper and lower chambers, or in the lower chamber alone (air/liquid interface). After 4 or 8 days of primary culture with daily medium changes, the cells were harvested and the proteins were subjected to immunoblotting for analysis of SP-A. As described above, when the enriched type II cell preparation was cultured in dishes coated with ECM, the levels of SP-A protein were elevated and increased between days 4 and 8 of culture (ECM lanes, Figure 6). When the cells were cultured in the TranswellTM dishes at an air/liquid interface (membrane/air lanes, Figure 6), the levels of immunoreactive SP-A were increased to levels greater than those of the cells cultured on the ECM-coated culture dishes. By contrast, when the type II cells were cultured in the TranswellTM dishes with medium in both upper and lower chambers (membrane/media lanes, Figure 6), the levels of immunoreactive SP-A were reduced markedly as compared with cells cultured in TranswellTM dishes at an air/ liquid interface or in the ECM-coated culture dishes. In fact, the levels of SP-A protein in the cells cultured in the TranswellTM dishes with medium in upper and lower chambers declined between days 4 and 8 of culture, suggesting a loss of the type II cell phenotypic properties. These findings indicate that culture of type II pneumonocytes at an air/liquid interface contributes to the maintenance of a differentiated phenotype.
|
Expression of SP-A in Isolated Type II Pneumonocytes in Primary Culture Depends on the Volume of Medium
In consideration of the findings using the TranswellTM
dishes, it was of interest to determine the effects of medium volume on SP-A expression in type II cells cultured
in ECM-coated dishes. Type II pneumonocytes were incubated in 60-mm ECM-coated culture dishes containing 0.25-
3.0 ml of serum-free medium containing Bt2cAMP for 5 days. The cells were harvested, and the levels of immunoreactive SP-A protein were analyzed as a marker of type II
pneumonocyte differentiation. As shown in the autoradiogram in Figure 7, the levels of SP-A were equivalent in cells
cultured in medium volumes
1.0 ml. However, at volumes
of medium > 1.0 ml the levels of immunoreactive SP-A
were decreased. These findings further suggest that culture
of type II cells at an air/liquid interface promotes maintenance of a differentiated phenotype.
|
Type II Pneumonocytes in Primary Culture Are Readily Infected by Recombinant Human Adenoviruses and Provide a System for Analysis of Gene Regulatory Elements Required for Cell-Specific Expression
We have used enriched populations of type II cells cultured on ECM-coated dishes to define genomic elements upstream of the rabbit (28, 39, 40) and human (41) SP-A genes that mediate cyclic AMP-regulated expression. In our initial studies, we found that traditional methods of DNA transfection, including use of calcium phosphate (42), DEAE-dextran (43), liposomes (44), and electroporation (45), were ineffective as means for transfer of DNA into the primary cultures of type II cells (unpublished observations). In fact, as mentioned above, we serendipitously observed that although DEAE-dextran was ineffective as a means for transfecting DNA into the isolated lung cells, it selectively eliminated fibroblasts, providing a means for enriching the cultures for type II cells (unpublished observations). We, therefore, turned to the use of recombinant replication-defective human adenoviruses (46), which are trophic for lung airway epithelial cells (47), for introduction of fusion genes comprised of various amounts of SP-A 5'-flanking DNA linked to the human growth hormone (hGH) structural gene into the type II cells in primary culture.
It should be noted that the lung cell cultures are comprised of islands of type II cells surrounded by fibroblasts.
To validate the use of this system for studies to define regions of the SP-A gene that mediate type II cell-specific
expression, it is important to determine whether both type
II cells and fibroblasts are infected by the recombinant adenoviruses and whether one or both cell types have the capacity to express the SP-A:hGH fusion genes. To address these issues, in the present study, we infected the enriched
type II cell cultures with two recombinant adenoviruses,
AdSP-A
991:hGH (28) and AdCMV:lac (29). Human fetal
lung cells were isolated by collagenase treatment of lung
explants that had been incubated for 5 days in medium
containing Bt2cAMP. Half of the cell suspension was
treated with DEAE-dextran to reduce the number of fibroblasts; the remainder was not treated with DEAE-dextran. Both cell suspensions were plated onto ECM-coated
Thermonox glass coverslips and cultured for 2 days in Waymouth's medium containing Bt2cAMP. On the third day of
culture, the cells were simultaneously infected for 1 h with
107 plaque-forming units (PFU) of AdSP-A
991:hGH and
AdCMV:lac. A multiplicity of infection (m.o.i.) of 3 for
each recombinant adenovirus was used so that essentially all
of the cells would be transfected with each gene construct.
Three days later, the cells were fixed on the coverslips and
stained for the presence of
-galactosidase and hGH.
Light micrographs of the adenovirus infected cells
stained for
-galactosidase and hGH are shown in Figures
8A and 8B. The type II cell cultures shown in Figure 8A
were prepared using DEAE-dextran treatment to selectively remove fibroblasts, as described in MATERIALS AND
METHODS. The cultures shown in Figure 8B were prepared without DEAE-dextran treatment to more critically
evaluate cell-specific expression of AdSP-A
991:hGH. Since
the CMV:lacZ expression vector contains a nuclear localization signal, expression of AdCMV:lac is reflected by blue
staining for
-galactosidase in cell nuclei. Expression of
AdSP-A
991:hGH was assessed by immunocytochemistry for hGH and is indicated by the presence of red granules
in the cytoplasm. As can be seen by the blue staining of
the nuclei, it is evident that nearly all of the epithelial cells
and fibroblasts were infected and express
-galactosidase
from the AdCMV:lac adenovirus (Figures 8A and 8B), demonstrating the efficiency of transfection cells by adenovirus. By contrast, only cells with an epithelial cell morphology were immunoreactive for hGH. This finding suggests that, whereas the lung epithelial cells contain transcription factors that interact with elements within the 991 bp SP-A
gene 5'-flanking region, the fibroblasts do not. The absence of staining for
-galactosidase or hGH in some of
the cells may be due to the fact that adenoviruses are replication defective in cells that do not express E1a (48). Therefore, when a cell divides, it is possible that one of the daughter cells may not contain adenoviral DNA. These findings
indicate that the primary type II cell cultures can effectively
be used to functionally map cis-acting elements that mediate type II cell-specific expression of SP-A promoter activity (28, 39).
|
To characterize the expression of recombinant adenoviruses for use in promoter studies, we analyzed hGH production in type II cells infected with AdSP-A
991:hGH adenovirus as a function of increasing m.o.i. from 0.1 to 10, and as a
function of increasing numbers of cells at a constant number
of PFU, where the number of infectious viral particles becomes limiting (Figure 9). Human type II pneumonocytes
were cultured and infected with recombinant adenovirus as
described in MATERIALS AND METHODS with the following modifications. In the study shown in Figure 9A, the number
of type II cells was maintained at a constant level (4 × 106
cells per dish), while the number of infectious viral particles added to the cells was varied from 4 × 105 to 4 × 107 PFU
per dish, resulting in increasing gene dosage per cell. In the
parallel study shown in Figure 9B, the number of type II
cells was varied from 105 to 107 cells per dish, while the
number of PFU was constant at 106, resulting in a decrease
in the m.o.i. After 5 days of culture in serum-free medium
without Bt2cAMP, the media were collected and the amount
of hGH produced was analyzed. As shown in Figure 9A,
as the number of recombinant adenoviral particles was increased from an m.o.i. of 0.1 to 10, hGH production was
increased in a linear fashion. These findings indicate hGH
expression increases in a linear manner with increased
AdSP-A
991:hGH infection up to an m.o.i. as high as 10, and suggest that the concentration of transcription factors
within the type II cells that interact with the SP-A promoter
do not become limiting under these conditions. As shown
in Figure 9B, when the number of infectious viral particles became limiting relative to the number of type II cells, so
that the m.o.i. was
0.3, hGH expression reached a constant level. In previous studies (28, 39), we found that
hGH expression by transfected type II cells was highly reproducible from one experiment to another for each fusion gene construct under the same treatment and assay
conditions when the m.o.i. was within the range of 0.15-0.20.
Under these conditions, expression of the AdSP-A
991:hGH
was readily detectable under basal conditions, and alterations in expression upon addition of various factors (i.e.,
Bt2cAMP, dexamethasone) could readily be assessed (28, 39).
|
| |
Discussion |
|---|
|
|
|---|
The lack of alveolar epithelial cell lines that manifest both morphologic properties and gene expression patterns of type II pneumonocytes has hampered studies to define the molecular mechanisms involved in type II cell-specific gene regulation, and in surfactant synthesis, processing, secretion, and reutilization. Although murine lung epithelial (MLE) cell lines have been established from distal bronchiolar/alveolar lung tumors of transgenic mice carrying the simian virus 40 (SV40) large tumor antigen under control of the human SP-C promoter (49), these cell lines express some, but not all of the cellular markers characteristic of type II cells. For example, the MLE-15 cell line was reported to be comprised of subsets of cells that contained multilamellar inclusion bodies and relatively high levels of SP-B mRNA, whereas SP-A mRNA was found to be present at low levels and SP-C mRNA was undetectable. On the other hand, the MLE-12 cell line expressed SP-C mRNA; however, SP-A mRNA was undetectable and lamellar bodies were absent.
Thus, there has been considerable effort by a number of laboratories to develop methods for primary culture of type II pneumonocytes which maintain a differentiated phenotype for an extended period of time in monolayer culture. In the present study, we have developed a relatively simple method for isolation and culture of type II pneumonocytes isolated from midgestation human fetal lung explants. Since SP-A gene expression is initiated in fetal lung tissue in closer association with the induction of surfactant glycerophospholipid synthesis and the appearance of differentiated type II cells than the surfactant proteins SP-B, -C, and -D, we have focused on SP-A as a marker of the differentiated state.
In previous studies, we observed that midgestation human fetal lung explants differentiate spontaneously when maintained in organ culture in serum-free defined medium (15). Essentially all of the epithelial cells lining the prealveolar ducts differentiate into type II cells containing numerous lamellar bodies. It was found that ~ 50% of the cells in the cultured fetal lung explants had the morphologic characteristics of type II cells (16). Thus, the proportion of type II cells in the cultured fetal lung tissue is markedly increased as compared with adult lung tissue, in which it is estimated that ~ 10-20% of the cells are type II cells (50). Furthermore, we previously observed that treatment of human fetal lung explants with Bt2cAMP increases the size of the prealveolar ducts, enhances the rate of type II cell differentiation, and increases transcriptional activity of the SP-A gene (16). In consideration of the increased proportion of type II cells and elevated levels of SP-A gene transcription in cyclic AMP treated human fetal lung explants we chose to use these tissues as the source of type II cells for the primary culture system. The same technique also has been successfully applied to the isolation and culture of type II cells from fetal rat (28) and rabbit lung tissues (Alcorn, Smith, and Mendelson; unpublished observations).
The mechanisms whereby cyclic AMP enhances the rate of type II cell differentiation have not been defined. In previous studies to determine the mechanisms whereby cyclic AMP increases transcriptional activity of the SP-A gene, we identified conserved cyclic AMP-response element (CRE)-like sequences upstream of the rabbit (28, 40) and human (41) SP-A2 genes. In studies to characterize the transcription factors that bind to this element, it was found that neither cyclic AMP-response element-binding protein (CREB), cyclic AMP-response element modulator (CREM), or activating transcription factor-1 (ATF-1) bind to this site (40). Rather, it appears that this sequence may serve as a binding site for a member of the nuclear receptor superfamily (40). This is of interest, since several members of this gene family are known to serve important roles in cellular differentiation (51, 52).
In previous attempts to transfect DNA into freshly isolated human fetal type II cells, we made the serendipitous observation that treatment of collagenase-dispersed fetal lung explants with DEAE-dextran (which was ineffective in promoting DNA transfection) caused a selective depletion of fibroblasts from the cell suspension, without substantially altering the number of type II cells. After plating of this enriched type II cell suspension on extracellular matrix, the type II cells aggregate to form islands that are surrounded by small numbers of fibroblasts. Since the cells are placed in serum-free medium after the first day of culture, fibroblasts are maintained at relatively low numbers. In consideration of the possible importance of type II cell-fibroblast interactions in the maintenance of type II cell differentiation (53), we elected to carry out our studies using this type II cell-enriched culture system rather than attempting to create pure type II cells cultures.
The findings obtained in this study suggest that culture
of these cells at an air-liquid interface is of great importance in the maintenance of type II cell differentiation, an
effect previously noted by Yamaya and associates (54) and
Whitcutt and colleagues (55) in their studies of trachea epithelial cell differentiation. This finding was particularly
evident in the studies using TranswellTM dishes, in which
medium was placed either in the lower chamber alone, or
in upper and lower chambers of the dish. When type II
cells were cultured in TranswellTM dishes that contained medium only in the lower chamber, so that the cells were maintained at an air-liquid interface, the levels of SP-A expression were markedly increased as compared with cells
cultured with medium in the upper as well as lower chambers. Furthermore, when type II cells were incubated on
ECM in 60-mm tissue culture dishes, the levels of SP-A expression were increased when the volume of culture medium was
1.0 ml as compared with cells cultured in larger
amounts of medium. Therefore, under conditions in which the cells are immersed in medium, the levels of SP-A expression are decreased. These findings are of interest, since the
type II cell exists at an air-liquid interface within the alveolus. As a result, the type II cell, together with the type I cell, are exposed to unique surface forces, and a higher oxygen
tension than is any other cell type in the body.
The findings of our previous studies suggest that oxygen plays a permissive role in the spontaneous differentiation of midgestation human fetal lung explants in culture
at both morphologic and biochemical levels (19). When fetal lung explants were maintained in organ culture at an
oxygen tension of 1%, SP-A mRNA and protein failed to
increase spontaneously with time in culture and there was
no inductive effect of Bt2cAMP. Furthermore, when cultured in a 1% oxygen-containing environment, the volume
densities of the lumina of the prealveolar ducts and of the
epithelium lining those ducts were markedly reduced as
compared with explants maintained in a 20% oxygen-containing environment; again, cyclic AMP had no inductive
effect on morphologic development. When fetal lung tissues that had been maintained in 1% oxygen were placed
in a 20% oxygen environment, there was rapid enlargement of the prealveolar ducts and an induction of SP-A
gene expression (19). In oxygen "dose-response" studies,
we also observed that the inductive effects of cyclic AMP
on SP-A gene expression and on morphologic development were prevented when the oxygen tension was reduced to levels
5%. Whereas, the spontaneous increase
in volume density of the alveolar lumina and of epithelial
cells were maximal at an oxygen tension of
10%, the
stimulatory effect of cyclic AMP on SP-A mRNA levels was far greater at 20% oxygen than at lower oxygen tensions. In those studies, we also observed that SP-C expression was markedly reduced in the human fetal lung explants at low oxygen tension (19).
In light of these findings, we suggest that increased oxygen availability to type II cells cultured at an air-liquid interface may contribute to promotion and maintenance of
type II cell differentiation and the induction of SP-A gene
expression. Alternatively, cell polarization is likely increased by culture of the type II cells at an air-liquid interface, and this may contribute to maintenance of the differentiated state. It is evident from the DNA transfection studies that the cultured type II cells have retained the transcription factors required to mediate expression of SP-A
promoter activity. In those experiments, we found that although both lung fibroblasts and type II cells were equivalently infected by recombinant adenoviruses and have the
ability to express
-galactosidase under control of the CMV
promoter, only the type II cells had the capacity to express
SP-A:hGH fusion genes containing 991 bp of 5'-flanking sequence from the rabbit SP-A gene. Based on these findings, we conclude that the primary type II cell culture system reported herein will provide a suitable means for mapping of genomic elements required for expression of type
II cell-specific genes. It will be of interest to determine
whether these cells retain the ability to process, secrete,
and metabolize surfactant components in a manner similar
to that of type II cells in situ.
| |
Footnotes |
|---|
Address correspondence to: Carole R. Mendelson, Ph.D., Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75235-9038. E-mail: cmende{at}biochem.swmed.edu
(Received in original form December 2, 1996 and in revised form March 4, 1997).
Acknowledgments: This research was supported in part by National Heart, Lung, and Blood Institute grant R01-HL-50022, and by Basic Research Grant 1-FY96-1070 from the March of Dimes Birth Defects Foundation.
Abbreviations ATF-1, activating transcription factor-1; CREB, cyclic AMP- response element-binding protein; CREM, cyclic AMP-response element modulator; ECM, extracellular matrix; hGH, human growth hormone; MDCK, Madin-Darby canine kidney; m.o.i., multiplicity of infection; MLE, murine lung epithelial; PBS, phosphate-buffered saline; PFU, plaque-forming units; SDS-PAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis; SV40, simian virus 40.
| |
References |
|---|
|
|
|---|
1. Clements, J. A., and R. J. King. 1976. Composition of surface active material. In The Biochemical Basis of Pulmonary Function. R. G. Crystal, editor. Marcel Dekker, New York. 363-387.
2. Hawgood, S., and K. Schiffer. 1991. Structure and properties of surfactant-associated proteins. Annu. Rev. Physiol 53: 375-395 [Medline].
3. Haagsman, H. P., and L. M. G. van Golde. 1991. Regulation of surfactant synthesis and secretion. Annu. Rev. Physiol 53: 441-461 [Medline].
4. Ballard, P. L.. 1989. Hormonal regulation of pulmonary surfactant. Endo. Rev 10: 165-181 . [Medline]
5. Mendelson, C. R., and V. Boggaram. 1991. Hormonal control of the surfactant system in fetal lung. Annu. Rev. Physiol 53: 415-440 [Medline].
6. Auten, R. L., R. H. Watkins, D. L. Shapiro, and S. Horowitz. 1990. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am. J. Respir. Cell Mol. Biol 3: 491-496 .
7. Wohlford-Lenane, C. L., and J. M. Snyder. 1992. Localization of the surfactant proteins SP-A and SP-B mRNA in fetal rabbit lung tissue by in situ hybridization. Am. J. Respir. Cell Mol. Biol 7: 335-342 .
8.
Ballard, P. L.,
S. Hawgood,
H. Liley,
G. Wellenstein,
L. W. Gonzales,
B. Benson,
B. Cordell, and
R. T. White.
1986.
Regulation of the pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung.
Proc. Natl. Acad.
Sci. USA
83:
9527-9531
9. Snyder, J. M., J. E. Kwun, J. A. O'Brien, C. R. Rosenfeld, and M. J. Odom. 1988. The concentration of the 35 kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr. Res 24: 728-734 [Medline].
10. Suzuki, Y., Y. Fujita, and K. Kogishi. 1989. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am. Rev. Respir. Dis. 140: 75-81 [Medline].
11.
Hawgood, S.,
B. J. Benson,
J. Schilling,
D. Damm,
J. A. Clements, and
R. T. White.
1987.
Nucleotide and amino acid sequences of the pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP
28-36 in surfactant lipid adsorption.
Proc. Natl. Acad. Sci. USA
84:
66-70
12.
Wright, J. R.,
R. E. Wager,
S. Hawgood,
L. Dobbs, and
J. A. Clements.
1987.
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
J. Biol. Chem.
262:
2888-2894
13.
Tenner, A. J.,
S. L. Robinson,
J. Borchelt, and
J. R. Wright.
1989.
Human
pulmonary surfactant protein (SP-A), a protein structurally homologous
to C1q can enhance FcR- and CR1-mediated phagocytosis.
J. Biol. Chem
264:
13923-13928
14. Pison, U., M. Max, A. Neuendank, S. Weissbach, and S. Pietschmann. 1994. Host defence capacities of pulmonary surfactant: evidence for `non-surfactant' functions of the surfactant system. Eur. J. Clin. Invest 24: 586-599 [Medline].
15. Snyder, J. M., C. R. Mendelson, and J. M. Johnston. 1981. The effect of cortisol on rabbit fetal lung maturation in vitro. Dev. Biol 85: 126-140 .
16.
Odom, M. J.,
J. M. Snyder, and
C. R. Mendelson.
1987.
Adenosine 3',5'-monophosphate analogs and
-adrenergic agonists induce the synthesis of
the major surfactant apoprotein in human fetal lung in vitro.
Endocrinology
121:
1155-1163
[Abstract].
17. Boggaram, V., M. E. Smith, and C. R. Mendelson. 1991. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol. Endocrinol. 5: 414-423 [Abstract].
18. Acarregui, M. J., J. M. Snyder, M. D. Mitchell, and C. R. Mendelson. 1990. Prostaglandins regulate surfactant protein A (SP-A) gene expression in human fetal lung in vitro. Endocrinology 127: 1105-1113 [Abstract].
19.
Acarregui, M. J.,
J. M. Snyder, and
C. R. Mendelson.
1993.
Oxygen regulates the differentiation of human fetal lung in vitro and its responsiveness to cAMP.
Am. J. Physiol
264:
L465-L474
20. Mason, R. J., S. R. Walker, B. A. Shields, J. E. Henson, and M. C. Williams. 1985. Identification of rat alveolar type II epithelial cells with tannic acid and polychrome stain Am. Rev. Respir. Dis 131: 786-788 [Medline].
21. Hayat, M. A. 1986. Basic Techniques for Transmission Electron Microscopy. Academic Press, Inc., Orlando, FL. 56-196.
22.
Alcorn, J. L.,
Q. Chen,
V. Boggaram, and
C. R. Mendelson.
1992.
Expression and transport of rabbit surfactant protein A in COS-1 cells.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
262:
L437-L445
23.
Mendelson, C. R.,
C. Chen,
V. Boggaram,
C. Zacharias, and
J. M. Snyder.
1986.
Regulation of the synthesis of the major surfactant apoprotein in
rabbit lung tissue.
J. Biol. Chem
261:
9938-9943
24. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299 [Medline].
25.
Boggaram, V.,
Q. Kuang, and
C. R. Mendelson.
1988.
The major apoprotein of rabbit pulmonary surfactant: elucidation of primary sequence and
cAMP and developmental regulation.
J. Biol. Chem
263:
2939-2947
26.
Margana, R. K., and
V. Boggaram.
1995.
Transcription and mRNA stability
regulate developmental and hormonal expression of the rabbit surfactant
protein B gene.
Am. J. Physiol
268:
L481-L490
27.
Boggaram, V., and
R. K. Margana.
1993.
Developmental and hormonal regulation of surfactant protein C (SP-C) gene expression in fetal lung: role of
transcription and mRNA stability.
J. Biol. Chem
269:
27767-27772
28. Alcorn, J. L., E. Gao, Q. Chen, M. E. Smith, R. D. Gerard, and C. R. Mendelson. 1993. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene. Mol. Endocrinol 7: 1072-1085 [Abstract].
29.
Herz, J., and
R. D. Gerard.
1993.
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in
normal mice.
Proc. Natl. Acad. Sci. USA
90:
2812-2816
30.
Boggaram, V., and
C. R. Mendelson.
1988.
Transcriptional regulation of the
gene encoding the major surfactant protein (SP-A) in fetal rabbit lung.
J. Biol. Chem
263:
19060-19065
31.
Boggaram, V.,
M. E. Smith, and
C. R. Mendelson.
1989.
Transcriptional
regulation of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro: disparate effects of glucocorticoids on transcription and mRNA stability.
J. Biol. Chem
264:
11421-11427
32. Smith, M. E., J. L. Alcorn, V. Boggaram, and C. R. Mendelson. 1989. Human alveolar type II cells in primary culture: retention of differentiated state and cyclic AMP responsiveness J. Cell Biol 109: A129 . (Abstr.) .
33. Shannon, J. M., R. J. Mason, and S. D. Jennings. 1987. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions, and cell-cell interactions. Biochim. Biophys. Acta 931: 143-156 [Medline].
34. Shannon, J. M., P. A. Emrie, J. H. Fisher, Y. Kuroki, S. D. Jennings, and R. J. Mason. 1990. Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult alveolar type II cells. Am. J. Respir. Cell Mol. Biol 2: 183-192 .
35. Stratton, C. J. 1984. Morphology of surfactant producing cells and the alveolar lining. In Pulmonary Surfactant. B. Robertson, L. M. G. Van Golde, and J. J. Batenburg, editors. Elsevier Science Publishers, Amsterdam. 67-118.
36. Okazaki, T., J. M. Johnston, and J. M. Snyder. 1982. Morphogenesis of the lamellar body in fetal lung tissue in vitro. Biochim. Biophys. Acta 712: 283-291 [Medline].
37. Paine, R. III, M. Joyce-Brady, A. Clement, and J. S. Brody. 1990. Serum accelerates the loss of type II cell differentiation in vitro. Am. J. Respir. Cell Mol. Biol 3: 311-323 .
38. Odom, M. J., J. M. Snyder, V. Boggaram, and C. R. Mendelson. 1988. Glucocorticoid regulation of the major surfactant-associated protein (SP-A) and its mRNA and of morphological development of human fetal lung in vitro. Endocrinology 121: 1155-1163 .
39.
Gao, E.,
J. L. Alcorn, and
C. R. Mendelson.
1993.
Identification of enhancers in the 5'-flanking region of the surfactant protein A (SP-A) gene and
characterization of their binding proteins.
J. Biol. Chem
268:
19697-19709
40. Michael, L. F., J. L. Alcorn, E. Gao, and C. R. Mendelson. 1996. Characterization of the cyclic adenosine 3'5'-monophosphate response element of the rabbit surfactant protein-A gene: evidence for transactivators distinct from CREB/ATF family members. Mol. Endocrinol 10: 159-170 [Abstract].
41.
Young, P. P., and
C. R. Mendelson.
1996.
A CRE-like element plays an essential role in cAMP regulation of human SP-A2 gene in alveolar type II
cells.
Am. J. Physiol
271:
L287-L299
42. Graham, F. L., and A. J. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-462 [Medline].
43.
Sussman, J. J., and
G. Milman.
1984.
Short-term, high-efficiency expression
of transfected DNA.
Mol. Cell. Biol
4:
1641-1643
44.
Fraley, R.,
S. Subramani,
P. Berg, and
D. Papahadjopoulous.
1980.
Introduction of liposome-encapsulated SV40 DNA into cells.
J. Biol. Chem
255:
10431-10435
45. Bertling, W., K. Hunger-Bertling, and M. J. Cline. 1987. Intracellular uptake and persistence of biologically active DNA after electroporation of mammalian cells J. Biochem. Biophys. Meth 14: 223-232 [Medline].
46. Graham F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology, Vol. 7. E. J. Murray, editor. Humana Press, Clifton, NJ. 109-123.
47. Mastrangeli, A., C. Danel, M. A. Rosenfeld, L. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1993. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91: 225-234 .
48.
Graham, F. L.,
J. Smiley,
W. C. Russell, and
R. Nairn.
1977.
Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
J. Gen. Virol
36:
59-72
49.
Wikenheiser, K. A.,
D. K. Vorbroker,
W. R. Rice,
J. C. Clark,
C. J. Bachurski,
H. K. Oie, and
J. A. Whitsett.
1993.
Production of immortalized distal
respiratory cell lines from surfactant protein C/simian virus 40 large T antigen transgenic mice
Proc. Natl. Acad. Sci. USA
90:
11029-11033
50. Stone, K. C., R. R. Mercer, P. Gehr, B. Stockstill, and J. D. Crapo. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol 6: 235-243 .
51. Lala, D. S., D. A. Rice, and K. L. Parker. 1992. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol. Endocrinol 6: 1249-1258 [Abstract].
52. Gotteland, M., E. May, F. May-Levin, G. Contesso, J. C. Delarue, and H. Mouriesse. 1994. Estrogen receptors (ER) in human breast cancer: the significance of a new prognostic factor based on both ER protein and ER mRNA contents. Cancer 74: 864-871 [Medline].
53.
Shannon, J. M.,
S. D. Jennings, and
L. D. Nielsen.
1992.
Modulation of alveolar type II cell differentiation in vitro.
Am. J. Physiol
262:
L427-L436
54. Yamaya, M., W. E. Finkbeiner, S. Y. Chun, and J. H. Widdicombe. 1992. Differentiated structure and function of cultures from human trachea epithelium. Am. J. Physiol. 262(Lung Cell. Mol. Physiol. 6):L713-L724.
55. Whitcutt, M. J., K. B. Alder, and R. Wu. 1988. A biphasic chamber system for maintaining polarity of differentiation of cultured respiratory tract epithelial cells. In Vitro Cell. Dev. Biol. 24: 420-428 [Medline].
This article has been cited by other articles:
![]() |
H. W. Huang, W. Bi, G. N. Jenkins, and J. L. Alcorn Glucocorticoid Regulation of Human Pulmonary Surfactant Protein-B mRNA Stability Involves the 3'-Untranslated Region Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 473 - 482. [Abstract] [Full Text] [PDF] |
||||
|
|